Monell study uncovers dual role of mammalian sweet taste receptor in regulating blood sugar levels

FHS
May 17, 2024
7:58 pm

The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of four teams in 2001 that found and described the mammalian sweet taste receptor – TAS1R2-TAS1R3.

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to

October 5, 2023

Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens

Reminding parents of tweens who were due for a human papillomavirus (HPV) vaccine increased uptake, especially when combined with auditing healthcare professionals after appointments, a

November 21, 2023

Biotech execs say IRA is causing unintended effects for cancer drug development – Pharmaceutical Technology

Share this article Experts from Roche, Blueprint Medicines, BeiGene, and Lyell Immunopharma discussed the impact of IRA on drug development. Credits: BIO/ https://bcic.bio.org Though elements

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.